脱毒桐籽饼(粕)蛋白质及能量营养价值评价

选用8头30kg的阉公猪和6只1.7kg的伊莎褐公鸡分别对3种脱毒桐籽饼(粕)Ⅰ、Ⅱ和Ⅲ的蛋白质、氨基酸消化率、代谢率进行了测定。结果表明 :3种脱毒桐饼(粕)Ⅰ、Ⅱ和Ⅲ的蛋白质含量分别为31.17 %、35.12 %和23.98 % ;总氨基酸含量为226.93mg/g、278.38mg/g和178.71mg/g,其中赖氨酸含量4.14mg/g、5.01mg/g和3.47mg/g ,蛋氨酸含量为1.24mg/g、1.33mg/g和0.92mg/g ;能量(GE)为17.72kJ/g、16.42kJ/g 和18.02kJ/g。脱毒桐粕Ⅰ的蛋白质消化率为75.15 % ,消化能为12.85MJ/kg;脱毒桐饼(粕)Ⅰ、Ⅱ的表观代谢能分别为4.88MJ/kg 和6.29MJ/kg,真代谢能为5.53MJ/kg 与6.94MJ/kg。3种脱毒桐饼(粕)的氨基酸之间存在不平衡状况 ,从限制性氨基酸的角度来看 ,脱毒桐饼(粕)的第一限制性氨基酸是蛋氨酸、第二限制性氨基酸为赖氨酸。     

无菌条件下野蔷薇种子快速催芽的研究

野蔷薇种子休眠深,发芽极不整齐,给育苗带来很大麻烦。以野蔷薇的3个无刺品系No.3、No.4、No.11和野蔷薇变种荷花蔷薇为试材,研究在无菌条件下,冷藏时间、GA3浓度和不同基质对野蔷薇种子发芽的影响,探索快速得到无菌实生苗的条件。结果表明:(1)影响野蔷薇种子萌发最主要的因素是冷藏时间;(2)3个无刺品系种子在冷藏10～15d、GA30.05～0.1mg/L处理时发芽率均在90%～100%,而荷花蔷薇种子在冷藏15d、GA30.05mg/L处理时最高发芽率为73%;(3)选用沙子作基质比蛭石更适合种子发芽。     

东北梅花鹿茸不同部位水解氨基酸含量的比较分析

对 10支东北梅花鹿茸作了不同部位水解氨基酸含量的比较分析 ,结果表明 ,水解氨基酸含量在东北梅花鹿茸腊片、粉片、血片和骨片各部位之间差异极显著 (P <0 0 1)。     

低蛋白质氨基酸平衡饲粮对早期断奶仔猪腹泻和生产性能的影响

本研究选用１８头２８±１日龄断奶的杂交仔猪（平均体重约５．５ｋｇ），研究低蛋白质氨基酸平衡饲粮对早期断奶仔猪腹泻和生产性能的影响。试验结果显示：（１）低蛋白质氨基酸平衡饲粮使仔猪血浆挥发性盐基氨含量、血浆尿素氨含量和腹泻指数降低（Ｐ＜０．０５或０．０１）。（２）采食全植物蛋白型氨基酸平衡饲粮（ＣＰ１８．３％）的仔猪，其平均日增重（ＡＤＧ）、平均日采食量（ＡＤＦＩ）和料肉比（Ｐ／Ｇ）与采食复合蛋白型对照饲粮（ＣＰ１９．７％）的仔猪差异不显著（Ｐ＞０．０５），但前者的增重成本比后者降低（Ｐ＜０．０５）３１％。（３）采食复合蛋白型氨基酸平衡饲粮（ＣＰ１８．４％）的仔猪的生产性能优于采食复合蛋白型对照饲粮（ＣＰ１９．７％）的仔猪，前者的ＡＤＧ和ＡＤＦＩ分别提高（Ｐ＜０．０５）６１％和３２％，Ｆ／Ｇ和增重成本分别下降（Ｐ＜０．０５）２４％和３７％。（４）采食全植物蛋白型氨基酸平衡饲粮的仔猪，其ＡＤＧ和ＡＤＦＩ低于（Ｐ＜０．０１）采食复合蛋白型氨基酸平衡饲粮的仔猪。前者的Ｆ／Ｇ和增重成本趋于高于后者，但差异不显著（Ｐ＞０．０５）。以上结果表明，低蛋白质氨基酸平衡饲粮可显著降低仔猪断奶后腹泻和提高仔猪生产性能。复合蛋白型?     

赖氨酸修饰对梯棱羊肚菌黑色素结构和理化特性的影响

为了进一步提高梯棱羊肚菌黑色素的提取率及溶解性,本试验采用单因素、Plackett-Burman试验、响应面试验对纤维素酶-超声波协同提取梯棱羊肚菌黑色素的提取工艺进行优化研究。通过赖氨酸修饰,并对修饰前后的梯棱羊肚菌黑色素进行结构表征、理化性质及稳定性研究。结果表明,在NaOH浓度为1.54 mol/L,纤维素酶添加量为20 mg/g,纤维素酶酶解时间为78.6 min,料液比为1:30,酶解温度为40 ℃,超声时间为80 min条件下提取的梯棱羊肚菌黑色素最优。未修饰的梯棱羊肚菌黑色素不溶于水,色价值为480.24,修饰后的黑色素溶解度为1 016 g/L,色价值为1 771.18,比未修饰的黑色素在溶解性、色价值方面均有所提高。此外,在不同的温度、光照、pH条件下,修饰前后的梯棱羊肚菌黑色素均比较稳定。以上研究结果为梯棱羊肚菌黑色素的高效提取及其产品的开发利用奠定了理论基础。     

Acquired resistance triggered by elicitins in tobacco and other plants

Elicitins are a family of proteins excreted byPhytophthora spp. They exhibit high sequence homology but large net charge differences. They induce necrosis in tobacco plants which then become resistant to the tobacco pathogenPhytophthora parasitica var.nicotianae. In stem-treated plants, resistance was not restricted to the site of elicitin application, but could be demonstrated by petiole inoculation at all levels on the stem. Resistance was already maximum after two days and lasted for at least two weeks. It was effective not only towardsP. p. var.nicotianae infection, but also against the unrelated pathogenSclerotinia sclerotiorum. In contrast to dichloroisonicotinic acid, an artificial inducer of systemic acquired resistance, which was increasingly effective with doses ranging from 0.25 to 5mole per plant, the basic elicitin cryptogein exhibited a threshold effect, inducing near total resistance and extensive leaf necrosis above 0.1 nmole per plant. Between 1 and 5 nmole, acidic elicitins (capsicein and parasiticein) protected tobacco plants with hardly any necrotic symptom. Elicitins exhibited similar effects in various tobacco cultivars andNicotiana species, although with quantitative differences, but induced neither necrosis nor protection in other SolanaceÆ (tomato, petunia and pepper). Among 24 additional species tested belonging to 18 botanical families, only some BrassicaceÆ, noticeably rape, exhibited symptoms in response to elicitins, in a cultivar-specific manner. Elicitins appear to be natural specific triggers for systemic acquired resistance and provide a tool for unraveling the mechanisms leading to its establishment.Abbreviations AR acquired resistance - HR hypersensitive response - INA 2,6-dichloroisonicotinic acid - Ppn Phytophthora parasitica var.nicotianae - SAR systemic acquired resistance     

In vitro expression and inhibition of procoagulant activity produced by bovine alveolar macrophages and peripheral blood cells

Local and systemic activation of coagulation is frequently associated with bacterial sepsis. The coagulopathy is due, at least in part, to expression of tissue factor (TF) by monocytes and macrophages. The purpose of this study was to evaluate the expression of procoagulant activity by bovine alveolar macrophages, leukocytes and platelets, and to determine the relative potency of three chemical inhibitors of TF expression (pentoxifylline, retinoic acid, and cyclosporin A). Bovine alveolar macrophages were stimulated with lipopolysaccharide (LPS) derived from Pasteurella haemolytica or recombinant bovine tumour nervous factor (TNF) and dose- and time-dependent effects on TF expression were studied. LPS and TNF induced TF expression in alveolar macrophages and LPS treatment of whole blood induced TF expression in mononuclear cells. Neutrophils and platelets also expressed procoagulant activity, but this activity was not inhibited by anti-bovine TF monoclonal antibody. Pentoxifylline (40 mol/L), retinoic acid (0.01 mmol/L) and cyclosporin A (0.08 mol/L) inhibited TF expression when added concurrently with LPS or TNF, but not when added 4 h after stimulation. TF mRNA was not detected in unstimulated alveolar macrophages by Northern blot analysis. In contrast, exposure to LPS or TNF for 6 h induced marked expression of TF mRNA, which was inhibited by treatment with pentoxifylline, retinoic acid and cyclosporin A. Expression of TNF by alveolar macrophages stimulated with LPS was also inhibited by these compounds. Our results indicate that procoagulant activity expressed by alveolar macrophages and monocytes is associated with expression of TF, whereas procoagulant activity expressed by neutrophils and platelets is not. The concentrations of pentoxifylline and retinoic acid necessary for inhibition of TF expression in vitro may not be achievable in vivo owing to their toxic effects. However, the in vitro concentration of cyclosporin A that inhibited TF expression did not exceed the plasma concentration observed in humans, and therefore may be useful for inhibition of TF expression in vivo.Abbreviations BAL bronchoalveolar lavage - LPS lipopolysaccharide - cDNA cloned deoxyribonucleic acid - cAMP cyclic adenosine monophosphate - GAPDH glyceraldehyde phosphate dehydrogenase - mRNA messenger ribonucleic acid - TF tissue factor - TNF tumour necrosis factor - DPBS Dulbecco's phosphate-buffered saline     

Determination of uric acid in canine serum and urine by high performance liquid chromatography

A reproducible high performance liquid chromatography (HPLC) method was developed for analysis of uric acid in canine serum and urine. The method consists of precipitating serum proteins with phosphotungstic acid prior to HPLC analysis. Urine is analyzed after dilution with buffer. Chromatography is performed on a reversed-phase C-18 column with UV detection at 292 nm. Sensitivity of the method will allow reproducible measurement of uric acid at concentrations of 0.05 mg/dl in serum and 0.1 mg/dl in urine. The HPLC method has been used to quantify hundreds of canine serum and urine samples. The method is superior to UV absorption or colorimetric methods because its lower limit of detection allows measurement of uric acid at concentrations found in canine serum and urine.